Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
Droy-Lefaix
M T
MT
I.H.B./IPSEN Research Laboratories, Le Plessis Robinson, France.
Drouet
Y
Y
Braquet
P
P
Géraud
G
G
D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004224:Diterpenes; D005260:Female; D005609:Free Radicals; D046934:Ginkgolides; D007410:Intestinal Diseases / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D007413:Intestinal Mucosa / Q000473:pathology; D007511:Ischemia; D007783:Lactones / Q000627:therapeutic use*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051381:Rats; D011919:Rats, Inbred Strains; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*; D013482:Superoxide Dismutase / Q000494:pharmacology
D004224:Diterpenes; D005609:Free Radicals; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; D000493:Allopurinol; C045856:ginkgolide B; D013482:Superoxide Dismutase; D004121:Dimethyl Sulfoxide